

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ketone body metabolic process (GO:1902224) | 8.71862871 |
| 2 | pigment biosynthetic process (GO:0046148) | 7.85745308 |
| 3 | melanocyte differentiation (GO:0030318) | 7.70849315 |
| 4 | vitamin A metabolic process (GO:0006776) | 7.57813129 |
| 5 | pigment cell differentiation (GO:0050931) | 7.06199313 |
| 6 | endosome to melanosome transport (GO:0035646) | 6.20546704 |
| 7 | endosome to pigment granule transport (GO:0043485) | 6.20546704 |
| 8 | melanosome organization (GO:0032438) | 6.19660442 |
| 9 | pigment metabolic process (GO:0042440) | 6.01065278 |
| 10 | pigment granule organization (GO:0048753) | 5.88192820 |
| 11 | regulation of endothelial cell chemotaxis (GO:2001026) | 5.33021681 |
| 12 | myotube differentiation (GO:0014902) | 4.94851415 |
| 13 | neuroepithelial cell differentiation (GO:0060563) | 4.94103193 |
| 14 | positive regulation of neuroblast proliferation (GO:0002052) | 4.70070809 |
| 15 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.65810934 |
| 16 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 4.56436118 |
| 17 | pigmentation (GO:0043473) | 4.45946939 |
| 18 | enteric nervous system development (GO:0048484) | 4.43912088 |
| 19 | aromatic amino acid family metabolic process (GO:0009072) | 4.17266381 |
| 20 | short-chain fatty acid metabolic process (GO:0046459) | 4.16196847 |
| 21 | melanosome localization (GO:0032400) | 4.12917515 |
| 22 | negative regulation of response to reactive oxygen species (GO:1901032) | 4.12907921 |
| 23 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 4.12141179 |
| 24 | platelet dense granule organization (GO:0060155) | 4.10941684 |
| 25 | phenol-containing compound metabolic process (GO:0018958) | 4.08574311 |
| 26 | melanosome transport (GO:0032402) | 4.06645907 |
| 27 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.00455669 |
| 28 | melanin biosynthetic process (GO:0042438) | 33.1129397 |
| 29 | melanin metabolic process (GO:0006582) | 30.0652546 |
| 30 | negative regulation of macroautophagy (GO:0016242) | 3.99775707 |
| 31 | pigment granule localization (GO:0051875) | 3.94600094 |
| 32 | establishment of melanosome localization (GO:0032401) | 3.86758941 |
| 33 | pigment granule transport (GO:0051904) | 3.86115728 |
| 34 | endothelial cell morphogenesis (GO:0001886) | 3.84189843 |
| 35 | establishment of pigment granule localization (GO:0051905) | 3.67986029 |
| 36 | proline transport (GO:0015824) | 3.52231722 |
| 37 | somatic stem cell division (GO:0048103) | 3.47188675 |
| 38 | regulation of neuroblast proliferation (GO:1902692) | 3.27650134 |
| 39 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.25314777 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23746879 |
| 41 | nerve growth factor signaling pathway (GO:0038180) | 3.18795792 |
| 42 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.10377762 |
| 43 | semaphorin-plexin signaling pathway (GO:0071526) | 3.08631923 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05246586 |
| 45 | cornea development in camera-type eye (GO:0061303) | 3.00200603 |
| 46 | secondary metabolite biosynthetic process (GO:0044550) | 27.5389117 |
| 47 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.99613087 |
| 48 | basement membrane organization (GO:0071711) | 2.91836586 |
| 49 | retinal metabolic process (GO:0042574) | 2.89520584 |
| 50 | regulation of protein sumoylation (GO:0033233) | 2.82903660 |
| 51 | peripheral nervous system development (GO:0007422) | 2.81187828 |
| 52 | keratinocyte development (GO:0003334) | 2.80614638 |
| 53 | muscle cell migration (GO:0014812) | 2.75071269 |
| 54 | sialylation (GO:0097503) | 2.74190980 |
| 55 | retinal rod cell development (GO:0046548) | 2.73954073 |
| 56 | intracellular pH reduction (GO:0051452) | 2.72498374 |
| 57 | barbed-end actin filament capping (GO:0051016) | 2.71036616 |
| 58 | mitotic G1/S transition checkpoint (GO:0044819) | 2.67772409 |
| 59 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.64983243 |
| 60 | fibroblast migration (GO:0010761) | 2.64100694 |
| 61 | G1 DNA damage checkpoint (GO:0044783) | 2.62498427 |
| 62 | inositol phosphate catabolic process (GO:0071545) | 2.60642928 |
| 63 | alanine transport (GO:0032328) | 2.55068840 |
| 64 | regulation of somitogenesis (GO:0014807) | 2.54632706 |
| 65 | cGMP-mediated signaling (GO:0019934) | 2.46736577 |
| 66 | bone remodeling (GO:0046849) | 2.46129878 |
| 67 | negative regulation of response to nutrient levels (GO:0032108) | 2.45171372 |
| 68 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.45171372 |
| 69 | negative regulation of organelle assembly (GO:1902116) | 2.43989338 |
| 70 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.43332204 |
| 71 | secretory granule organization (GO:0033363) | 2.42883502 |
| 72 | negative regulation of oxidative stress-induced cell death (GO:1903202) | 2.38068842 |
| 73 | dosage compensation (GO:0007549) | 2.37755560 |
| 74 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.35604725 |
| 75 | positive regulation of neural precursor cell proliferation (GO:2000179) | 2.34602019 |
| 76 | pH reduction (GO:0045851) | 2.34189553 |
| 77 | regulation of response to reactive oxygen species (GO:1901031) | 2.31071958 |
| 78 | negative regulation of response to oxidative stress (GO:1902883) | 2.28051807 |
| 79 | negative regulation of cellular response to oxidative stress (GO:1900408) | 2.28051807 |
| 80 | stem cell division (GO:0017145) | 2.26120105 |
| 81 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.25064062 |
| 82 | cellular response to reactive nitrogen species (GO:1902170) | 2.21688572 |
| 83 | cellular response to nitric oxide (GO:0071732) | 2.20356707 |
| 84 | regulation of centriole replication (GO:0046599) | 2.20253202 |
| 85 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.18298800 |
| 86 | polyol catabolic process (GO:0046174) | 2.16870343 |
| 87 | vesicle localization (GO:0051648) | 2.16193250 |
| 88 | chondroitin sulfate catabolic process (GO:0030207) | 2.15558254 |
| 89 | neural crest cell migration (GO:0001755) | 2.12714779 |
| 90 | behavioral response to ethanol (GO:0048149) | 2.12390417 |
| 91 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.11899874 |
| 92 | embryonic body morphogenesis (GO:0010172) | 2.11844339 |
| 93 | organic hydroxy compound biosynthetic process (GO:1901617) | 2.10008316 |
| 94 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.09941099 |
| 95 | cellular response to electrical stimulus (GO:0071257) | 2.08980292 |
| 96 | protein-chromophore linkage (GO:0018298) | 2.08733073 |
| 97 | acrosome reaction (GO:0007340) | 2.08398667 |
| 98 | Rap protein signal transduction (GO:0032486) | 2.08102386 |
| 99 | signal peptide processing (GO:0006465) | 2.03694408 |
| 100 | retinol metabolic process (GO:0042572) | 2.02703446 |
| 101 | response to methylmercury (GO:0051597) | 2.01566999 |
| 102 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.01259889 |
| 103 | tyrosine metabolic process (GO:0006570) | 13.8685651 |
| 104 | developmental pigmentation (GO:0048066) | 11.5924880 |
| 105 | phenol-containing compound biosynthetic process (GO:0046189) | 10.9407403 |
| 106 | secondary metabolic process (GO:0019748) | 10.7604073 |
| 107 | regulation of penile erection (GO:0060405) | 1.97866097 |
| 108 | regulation of superoxide anion generation (GO:0032928) | 1.93216156 |
| 109 | oligodendrocyte differentiation (GO:0048709) | 1.93177442 |
| 110 | plasma membrane fusion (GO:0045026) | 1.93037174 |
| 111 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 1.92861963 |
| 112 | establishment of nucleus localization (GO:0040023) | 1.92783222 |
| 113 | regulation of intracellular pH (GO:0051453) | 1.92388672 |
| 114 | 4-hydroxyproline metabolic process (GO:0019471) | 1.92347201 |
| 115 | Rac protein signal transduction (GO:0016601) | 1.91601411 |
| 116 | response to nitric oxide (GO:0071731) | 1.91096838 |
| 117 | negative regulation of TOR signaling (GO:0032007) | 1.90616652 |
| 118 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 1.90557144 |
| 119 | folic acid-containing compound biosynthetic process (GO:0009396) | 1.90517465 |
| 120 | osteoclast differentiation (GO:0030316) | 1.87650769 |
| 121 | cranial nerve development (GO:0021545) | 1.87526450 |
| 122 | regulation of cellular pH (GO:0030641) | 1.87260047 |
| 123 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.86029166 |
| 124 | proteasome assembly (GO:0043248) | 1.85578610 |
| 125 | response to nerve growth factor (GO:1990089) | 1.83316790 |
| 126 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.83316790 |
| 127 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 1.77629991 |
| 128 | autophagic vacuole fusion (GO:0000046) | 1.76511743 |
| 129 | positive regulation of receptor recycling (GO:0001921) | 1.75820987 |
| 130 | protein K6-linked ubiquitination (GO:0085020) | 1.75759889 |
| 131 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 1.75548759 |
| 132 | termination of RNA polymerase III transcription (GO:0006386) | 1.75548759 |
| 133 | positive regulation of glucose transport (GO:0010828) | 1.75138644 |
| 134 | negative regulation of histone methylation (GO:0031061) | 1.74293211 |
| 135 | peptidyl-lysine dimethylation (GO:0018027) | 1.70433574 |
| 136 | myelin assembly (GO:0032288) | 1.69878591 |
| 137 | regulation of translational fidelity (GO:0006450) | 1.69098909 |
| 138 | negative regulation of fatty acid metabolic process (GO:0045922) | 1.67883087 |
| 139 | regulation of oxidative stress-induced cell death (GO:1903201) | 1.67181307 |
| 140 | regulation of apoptotic cell clearance (GO:2000425) | 1.66067573 |
| 141 | positive chemotaxis (GO:0050918) | 1.64165348 |
| 142 | regulation of early endosome to late endosome transport (GO:2000641) | 1.62719037 |
| 143 | glycolytic process (GO:0006096) | 1.62669056 |
| 144 | fat-soluble vitamin metabolic process (GO:0006775) | 1.61718819 |
| 145 | establishment of mitotic spindle orientation (GO:0000132) | 1.58630746 |
| 146 | regulation of histone H3-K9 methylation (GO:0051570) | 1.57706973 |
| 147 | glycoprotein catabolic process (GO:0006516) | 1.53009738 |
| 148 | centrosome duplication (GO:0051298) | 1.50900651 |
| 149 | placenta development (GO:0001890) | 1.50660967 |
| 150 | negative regulation of membrane potential (GO:0045837) | 1.50180360 |
| 151 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 1.49973573 |
| 152 | positive regulation of osteoblast proliferation (GO:0033690) | 1.48601020 |
| 153 | regulation of cellular response to oxidative stress (GO:1900407) | 1.48367089 |
| 154 | inositol phosphate dephosphorylation (GO:0046855) | 1.48142333 |
| 155 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 1.48142333 |
| 156 | negative regulation of hormone biosynthetic process (GO:0032353) | 1.47968355 |
| 157 | negative regulation of hormone metabolic process (GO:0032351) | 1.47968355 |
| 158 | pyruvate metabolic process (GO:0006090) | 1.46569168 |
| 159 | cellular glucuronidation (GO:0052695) | 1.46289828 |
| 160 | dorsal/ventral axis specification (GO:0009950) | 1.44322683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 8.04501052 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.76379112 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.44713233 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.23699761 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.73252418 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.54359417 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.12029630 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.01811335 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.86922662 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.75334495 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.69186861 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.63085042 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.44873412 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31435145 |
| 15 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.24851981 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.22633091 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.22024703 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12982513 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.11189785 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.04959106 |
| 21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.04242109 |
| 22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 11.1250986 |
| 23 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.96304746 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.89206667 |
| 25 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.89196293 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.78714537 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.78516070 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77905728 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70633474 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.65550930 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64335931 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63849856 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63840463 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.63553585 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60527000 |
| 36 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.58282259 |
| 37 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.56338747 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56144677 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.53051218 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52840853 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48075972 |
| 42 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46273370 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44851246 |
| 44 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.44797891 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44049201 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43365766 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42784730 |
| 48 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.41495732 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37201705 |
| 50 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.36226330 |
| 51 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.35954899 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29931794 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29690484 |
| 54 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.29494782 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28851383 |
| 56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28561997 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28561997 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.28319907 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27721812 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26726579 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25667926 |
| 62 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24600079 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24484783 |
| 64 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.24459201 |
| 65 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.23728686 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23674146 |
| 67 | JUN_21703547_ChIP-Seq_K562_Human | 1.23145350 |
| 68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.22033025 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21835510 |
| 70 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20820502 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20599742 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19857929 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18579841 |
| 74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18299081 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17433648 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16975671 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16803854 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16803854 |
| 79 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.16514204 |
| 80 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16469475 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15478329 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14683041 |
| 83 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14490078 |
| 84 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14345392 |
| 85 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14012397 |
| 86 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.13814542 |
| 87 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.13512561 |
| 88 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.12655725 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11889225 |
| 90 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11825593 |
| 91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11292220 |
| 92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11060637 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10853306 |
| 94 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.08771888 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08147304 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07926517 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07560171 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07455216 |
| 99 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06680957 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06202527 |
| 101 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06170870 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05781455 |
| 103 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05538032 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05244205 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04788751 |
| 106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04351636 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04326046 |
| 108 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02943532 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02031638 |
| 110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02003577 |
| 111 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01840643 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00770945 |
| 113 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00331147 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00092541 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99090932 |
| 116 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98998266 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98935436 |
| 118 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98056083 |
| 119 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98018866 |
| 120 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97814564 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96865354 |
| 122 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.96595428 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96443527 |
| 124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95572373 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94715269 |
| 126 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94402025 |
| 127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93758505 |
| 128 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93391968 |
| 129 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93204802 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92909544 |
| 131 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92667377 |
| 132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92636250 |
| 133 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.92343525 |
| 134 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92098394 |
| 135 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92045985 |
| 136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91912896 |
| 137 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.91285012 |
| 138 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89934947 |
| 139 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89934290 |
| 140 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89934290 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89809351 |
| 142 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89606858 |
| 143 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89178355 |
| 144 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88982932 |
| 145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88289701 |
| 146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88250578 |
| 147 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88105510 |
| 148 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87625785 |
| 149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87331196 |
| 150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87233926 |
| 151 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87202401 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86760111 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86554808 |
| 154 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85714950 |
| 155 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85396996 |
| 156 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79861307 |
| 157 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.79824233 |
| 158 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79617422 |
| 159 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77540219 |
| 160 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.77275490 |
| 161 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76347136 |
| 162 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76309765 |
| 163 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76143428 |
| 164 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.74070196 |
| 165 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73368671 |
| 166 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73272619 |
| 167 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.73250961 |
| 168 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.72957308 |
| 169 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72802697 |
| 170 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.72284964 |
| 171 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.71954929 |
| 172 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70556219 |
| 173 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70455677 |
| 174 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.70450559 |
| 175 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68635316 |
| 176 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.68038664 |
| 177 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.67778383 |
| 178 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.67055883 |
| 179 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66950099 |
| 180 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.65941415 |
| 181 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.65631611 |
| 182 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.65302586 |
| 183 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65048721 |
| 184 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.64834196 |
| 185 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.64563857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 8.99276252 |
| 2 | MP0003136_yellow_coat_color | 5.60582397 |
| 3 | MP0005408_hypopigmentation | 5.59755459 |
| 4 | MP0000371_diluted_coat_color | 4.42095781 |
| 5 | MP0005257_abnormal_intraocular_pressure | 4.21697275 |
| 6 | MP0004381_abnormal_hair_follicle | 3.99728732 |
| 7 | MP0002095_abnormal_skin_pigmentation | 3.27524801 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 3.27366950 |
| 9 | MP0000015_abnormal_ear_pigmentation | 3.15309900 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 2.99610396 |
| 11 | MP0003878_abnormal_ear_physiology | 2.99610396 |
| 12 | MP0001324_abnormal_eye_pigmentation | 2.81872961 |
| 13 | MP0002075_abnormal_coat/hair_pigmentati | 2.54613247 |
| 14 | MP0003011_delayed_dark_adaptation | 2.50697367 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.45618283 |
| 16 | MP0002102_abnormal_ear_morphology | 2.34843788 |
| 17 | MP0001186_pigmentation_phenotype | 2.03561188 |
| 18 | MP0000372_irregular_coat_pigmentation | 10.7999709 |
| 19 | MP0005174_abnormal_tail_pigmentation | 1.91193575 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.73401818 |
| 21 | MP0005248_abnormal_Harderian_gland | 1.67843424 |
| 22 | MP0002938_white_spotting | 1.67224213 |
| 23 | MP0004885_abnormal_endolymph | 1.57034349 |
| 24 | MP0005197_abnormal_uvea_morphology | 1.31887056 |
| 25 | MP0002090_abnormal_vision | 1.26818019 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.24491113 |
| 27 | MP0005409_darkened_coat_color | 1.19719116 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.19329766 |
| 29 | MP0005253_abnormal_eye_physiology | 0.98758362 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 0.85839443 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 0.84865986 |
| 32 | MP0010094_abnormal_chromosome_stability | 0.82527363 |
| 33 | MP0001293_anophthalmia | 0.73648258 |
| 34 | MP0000733_abnormal_muscle_development | 0.66133629 |
| 35 | MP0000367_abnormal_coat/_hair | 0.65901162 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 0.65402654 |
| 37 | MP0003646_muscle_fatigue | 0.64735396 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 0.62744402 |
| 39 | MP0002092_abnormal_eye_morphology | 0.60074814 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 0.59466030 |
| 41 | MP0005391_vision/eye_phenotype | 0.58983538 |
| 42 | MP0008260_abnormal_autophagy | 0.58560681 |
| 43 | MP0006054_spinal_hemorrhage | 0.56461829 |
| 44 | MP0000377_abnormal_hair_follicle | 0.53132808 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 0.51087529 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 0.49981258 |
| 47 | MP0000762_abnormal_tongue_morphology | 0.49448615 |
| 48 | MP0005058_abnormal_lysosome_morphology | 0.47453852 |
| 49 | MP0004084_abnormal_cardiac_muscle | 0.47212979 |
| 50 | MP0006138_congestive_heart_failure | 0.44077285 |
| 51 | MP0005193_abnormal_anterior_eye | 0.43971964 |
| 52 | MP0010307_abnormal_tumor_latency | 0.43878964 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.42957308 |
| 54 | MP0005023_abnormal_wound_healing | 0.42458597 |
| 55 | MP0001485_abnormal_pinna_reflex | 0.39540786 |
| 56 | MP0001984_abnormal_olfaction | 0.37737890 |
| 57 | MP0002177_abnormal_outer_ear | 0.37706040 |
| 58 | MP0009697_abnormal_copulation | 0.35786017 |
| 59 | MP0001188_hyperpigmentation | 0.34875382 |
| 60 | MP0005623_abnormal_meninges_morphology | 0.33489140 |
| 61 | MP0000749_muscle_degeneration | 0.31471264 |
| 62 | MP0000920_abnormal_myelination | 0.30065129 |
| 63 | MP0003950_abnormal_plasma_membrane | 0.29462967 |
| 64 | MP0003567_abnormal_fetal_cardiomyocyte | 0.28238719 |
| 65 | MP0001849_ear_inflammation | 0.28020123 |
| 66 | MP0001851_eye_inflammation | 0.27698114 |
| 67 | MP0005275_abnormal_skin_tensile | 0.27151372 |
| 68 | MP0009840_abnormal_foam_cell | 0.25055206 |
| 69 | MP0003943_abnormal_hepatobiliary_system | 0.24667416 |
| 70 | MP0003111_abnormal_nucleus_morphology | 0.24587481 |
| 71 | MP0002751_abnormal_autonomic_nervous | 0.24376080 |
| 72 | MP0008770_decreased_survivor_rate | 0.23882257 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.23468933 |
| 74 | MP0008569_lethality_at_weaning | 0.22065638 |
| 75 | MP0003186_abnormal_redox_activity | 0.21873696 |
| 76 | MP0000358_abnormal_cell_content/ | 0.21697536 |
| 77 | MP0003091_abnormal_cell_migration | 0.21451843 |
| 78 | MP0001958_emphysema | 0.19771046 |
| 79 | MP0004233_abnormal_muscle_weight | 0.19742574 |
| 80 | MP0002822_catalepsy | 0.19705456 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 0.19429457 |
| 82 | MP0008932_abnormal_embryonic_tissue | 0.18882346 |
| 83 | MP0005503_abnormal_tendon_morphology | 0.17979855 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.17322663 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.17135337 |
| 86 | MP0002697_abnormal_eye_size | 0.16397916 |
| 87 | MP0004272_abnormal_basement_membrane | 0.16015499 |
| 88 | MP0003634_abnormal_glial_cell | 0.15017589 |
| 89 | MP0005187_abnormal_penis_morphology | 0.14872582 |
| 90 | MP0010678_abnormal_skin_adnexa | 0.14721180 |
| 91 | MP0004147_increased_porphyrin_level | 0.13958485 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.13746428 |
| 93 | MP0005670_abnormal_white_adipose | 0.11170591 |
| 94 | MP0002060_abnormal_skin_morphology | 0.10995868 |
| 95 | MP0003385_abnormal_body_wall | 0.10544701 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.10503150 |
| 97 | MP0005195_abnormal_posterior_eye | 0.10286575 |
| 98 | MP0002909_abnormal_adrenal_gland | 0.10074923 |
| 99 | MP0000427_abnormal_hair_cycle | 0.10054734 |
| 100 | MP0003632_abnormal_nervous_system | 0.09546682 |
| 101 | MP0000747_muscle_weakness | 0.09536570 |
| 102 | MP0004924_abnormal_behavior | 0.09301676 |
| 103 | MP0005386_behavior/neurological_phenoty | 0.09301676 |
| 104 | MP0008007_abnormal_cellular_replicative | 0.08787899 |
| 105 | MP0001270_distended_abdomen | 0.08726369 |
| 106 | MP0002269_muscular_atrophy | 0.08341354 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.07969369 |
| 108 | MP0000537_abnormal_urethra_morphology | 0.07835588 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.07726111 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.07541056 |
| 111 | MP0003938_abnormal_ear_development | 0.06797698 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.06194346 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.05645287 |
| 114 | MP0004087_abnormal_muscle_fiber | 0.05402635 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.05232386 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.04881833 |
| 117 | MP0003077_abnormal_cell_cycle | 0.04423314 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.04033112 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.03784856 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.03728551 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.03119211 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.02759064 |
| 123 | MP0003698_abnormal_male_reproductive | 0.02593822 |
| 124 | MP0009046_muscle_twitch | 0.02495108 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.02467908 |
| 126 | MP0003119_abnormal_digestive_system | 0.02170487 |
| 127 | MP0009703_decreased_birth_body | 0.02165226 |
| 128 | MP0001730_embryonic_growth_arrest | 0.02126038 |
| 129 | MP0005384_cellular_phenotype | 0.02034054 |
| 130 | MP0002229_neurodegeneration | 0.01798753 |
| 131 | MP0001697_abnormal_embryo_size | 0.01696200 |
| 132 | MP0002557_abnormal_social/conspecific_i | 0.01606288 |
| 133 | MP0000026_abnormal_inner_ear | 0.00988596 |
| 134 | MP0001756_abnormal_urination | 0.00920228 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.00919212 |
| 136 | MP0002064_seizures | 0.00164288 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.00016725 |
| 138 | MP0005220_abnormal_exocrine_pancreas | -0.0024819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ocular albinism (HP:0001107) | 9.19535911 |
| 2 | Hypopigmentation of the fundus (HP:0007894) | 8.94784303 |
| 3 | Iris hypopigmentation (HP:0007730) | 8.05369349 |
| 4 | Generalized hypopigmentation (HP:0007513) | 6.56448547 |
| 5 | White forelock (HP:0002211) | 6.13260806 |
| 6 | Subacute progressive viral hepatitis (HP:0006572) | 6.09118058 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 5.79135941 |
| 8 | Patchy hypopigmentation of hair (HP:0011365) | 5.46876224 |
| 9 | Hypoplasia of the iris (HP:0007676) | 4.89613913 |
| 10 | Freckling (HP:0001480) | 4.69504860 |
| 11 | Cutaneous melanoma (HP:0012056) | 4.61072938 |
| 12 | Heterochromia iridis (HP:0001100) | 4.31904326 |
| 13 | Generalized hypopigmentation of hair (HP:0011358) | 4.05033823 |
| 14 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.91980467 |
| 15 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 3.82484195 |
| 16 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.81534412 |
| 17 | Premature graying of hair (HP:0002216) | 3.68170910 |
| 18 | Viral hepatitis (HP:0006562) | 3.39613336 |
| 19 | Micronodular cirrhosis (HP:0001413) | 3.33903140 |
| 20 | Peripheral hypomyelination (HP:0007182) | 3.15185090 |
| 21 | Albinism (HP:0001022) | 3.09841455 |
| 22 | Hepatocellular carcinoma (HP:0001402) | 2.77374531 |
| 23 | Melanoma (HP:0002861) | 2.53409072 |
| 24 | Congenital stationary night blindness (HP:0007642) | 2.53047214 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40500451 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40500451 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40500451 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 2.24973837 |
| 29 | Cerebral hypomyelination (HP:0006808) | 2.23630524 |
| 30 | Decreased central vision (HP:0007663) | 2.07913119 |
| 31 | Abnormality of vision evoked potentials (HP:0000649) | 2.03677023 |
| 32 | Alacrima (HP:0000522) | 2.00597186 |
| 33 | Aplasia/Hypoplasia of the macula (HP:0008059) | 12.4345624 |
| 34 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 11.7586221 |
| 35 | Hypoplasia of the fovea (HP:0007750) | 11.7586221 |
| 36 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 11.6390470 |
| 37 | Blue irides (HP:0000635) | 11.0484804 |
| 38 | Abnormality of the fovea (HP:0000493) | 10.6139867 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 1.98237832 |
| 40 | Spastic diplegia (HP:0001264) | 1.87009070 |
| 41 | Abnormal auditory evoked potentials (HP:0006958) | 1.86886634 |
| 42 | Morphological abnormality of the inner ear (HP:0011390) | 1.84706953 |
| 43 | Large for gestational age (HP:0001520) | 1.84319960 |
| 44 | Scapular winging (HP:0003691) | 1.83601742 |
| 45 | Rhabdomyosarcoma (HP:0002859) | 1.79729085 |
| 46 | Amblyopia (HP:0000646) | 1.79715811 |
| 47 | Exercise-induced muscle cramps (HP:0003710) | 1.74503374 |
| 48 | Renal cell carcinoma (HP:0005584) | 1.73426414 |
| 49 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.71626452 |
| 50 | Cholecystitis (HP:0001082) | 1.69264082 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 1.69264082 |
| 52 | J-shaped sella turcica (HP:0002680) | 1.63978384 |
| 53 | Decreased lacrimation (HP:0000633) | 1.62443033 |
| 54 | Underdeveloped nasal alae (HP:0000430) | 1.62351546 |
| 55 | Hypermelanotic macule (HP:0001034) | 1.61314820 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.58274947 |
| 57 | Melanocytic nevus (HP:0000995) | 1.57548652 |
| 58 | Synophrys (HP:0000664) | 1.54375615 |
| 59 | Horizontal nystagmus (HP:0000666) | 1.53431896 |
| 60 | Ulnar claw (HP:0001178) | 1.53368420 |
| 61 | Photophobia (HP:0000613) | 1.53159536 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.51466166 |
| 63 | Mucopolysacchariduria (HP:0008155) | 1.51466166 |
| 64 | Poor head control (HP:0002421) | 1.50518429 |
| 65 | Lip pit (HP:0100267) | 1.49648249 |
| 66 | Abnormality of the anterior horn cell (HP:0006802) | 1.49259737 |
| 67 | Degeneration of anterior horn cells (HP:0002398) | 1.49259737 |
| 68 | Keratoconus (HP:0000563) | 1.48791614 |
| 69 | Increased corneal curvature (HP:0100692) | 1.48791614 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 1.46600233 |
| 71 | Astigmatism (HP:0000483) | 1.43702353 |
| 72 | Morphological abnormality of the middle ear (HP:0008609) | 1.42189123 |
| 73 | Hepatitis (HP:0012115) | 1.40298515 |
| 74 | Tongue fasciculations (HP:0001308) | 1.37933175 |
| 75 | Aplasia cutis congenita (HP:0001057) | 1.35975527 |
| 76 | Vertebral compression fractures (HP:0002953) | 1.35834689 |
| 77 | Neoplasm of the oral cavity (HP:0100649) | 1.34458520 |
| 78 | Conjunctival hamartoma (HP:0100780) | 1.33326333 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.31229746 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.31229746 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.31229746 |
| 82 | Adrenal hypoplasia (HP:0000835) | 1.30741290 |
| 83 | Abnormality of the anterior chamber (HP:0000593) | 1.25084425 |
| 84 | Hypokinesia (HP:0002375) | 1.23825949 |
| 85 | Hamartoma of the eye (HP:0010568) | 1.22552069 |
| 86 | Upper limb muscle weakness (HP:0003484) | 1.22192392 |
| 87 | Supernumerary ribs (HP:0005815) | 1.21749666 |
| 88 | Neoplasm of striated muscle (HP:0009728) | 1.21258573 |
| 89 | Neoplasm of the liver (HP:0002896) | 1.19821204 |
| 90 | Hypermetropia (HP:0000540) | 1.17702991 |
| 91 | Clumsiness (HP:0002312) | 1.17667266 |
| 92 | Loss of speech (HP:0002371) | 1.16983335 |
| 93 | Abnormality of the nasal septum (HP:0000419) | 1.16976977 |
| 94 | Aortic aneurysm (HP:0004942) | 1.16775095 |
| 95 | Hand muscle atrophy (HP:0009130) | 1.16204900 |
| 96 | Tented upper lip vermilion (HP:0010804) | 1.16113596 |
| 97 | Dysostosis multiplex (HP:0000943) | 1.15350487 |
| 98 | Impaired proprioception (HP:0010831) | 1.13889319 |
| 99 | Frequent falls (HP:0002359) | 1.13758988 |
| 100 | Facial cleft (HP:0002006) | 1.12882761 |
| 101 | Premature rupture of membranes (HP:0001788) | 1.12709966 |
| 102 | Akinesia (HP:0002304) | 1.12506689 |
| 103 | Ulnar deviation of finger (HP:0009465) | 1.11300169 |
| 104 | Muscle fibrillation (HP:0010546) | 1.10769788 |
| 105 | CNS hypomyelination (HP:0003429) | 1.10599032 |
| 106 | Cerebral aneurysm (HP:0004944) | 1.10245961 |
| 107 | Visual hallucinations (HP:0002367) | 1.07827628 |
| 108 | Narrow nasal bridge (HP:0000446) | 1.07820544 |
| 109 | Supernumerary nipples (HP:0002558) | 1.07255288 |
| 110 | Leukodystrophy (HP:0002415) | 1.07242665 |
| 111 | Global brain atrophy (HP:0002283) | 1.05671215 |
| 112 | Spastic paraplegia (HP:0001258) | 1.05514825 |
| 113 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.03945245 |
| 114 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.03308845 |
| 115 | Aganglionic megacolon (HP:0002251) | 1.02996285 |
| 116 | Spinal muscular atrophy (HP:0007269) | 1.02150511 |
| 117 | Constricted visual fields (HP:0001133) | 1.01681836 |
| 118 | Action tremor (HP:0002345) | 1.01380845 |
| 119 | Long toe (HP:0010511) | 1.01284529 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.00959376 |
| 121 | Postural tremor (HP:0002174) | 1.00865221 |
| 122 | Synostosis of carpal bones (HP:0005048) | 1.00726294 |
| 123 | Vascular tortuosity (HP:0004948) | 1.00619704 |
| 124 | Megalencephaly (HP:0001355) | 1.00120662 |
| 125 | Absent epiphyses (HP:0010577) | 0.99550371 |
| 126 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 0.99550371 |
| 127 | Diminished movement (HP:0002374) | 0.99350047 |
| 128 | Myelomeningocele (HP:0002475) | 0.98452547 |
| 129 | Decreased motor nerve conduction velocity (HP:0003431) | 0.97117580 |
| 130 | Insidious onset (HP:0003587) | 0.95527433 |
| 131 | Termporal pattern (HP:0011008) | 0.95527433 |
| 132 | Distal upper limb amyotrophy (HP:0007149) | 0.95497967 |
| 133 | Upper limb amyotrophy (HP:0009129) | 0.95497967 |
| 134 | Carpal synostosis (HP:0009702) | 0.94933145 |
| 135 | Proximal amyotrophy (HP:0007126) | 0.93822672 |
| 136 | Nasal speech (HP:0001611) | 0.92639029 |
| 137 | Tracheomalacia (HP:0002779) | 0.92203444 |
| 138 | Intestinal polyposis (HP:0200008) | 0.92011303 |
| 139 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 0.91680299 |
| 140 | Mesangial abnormality (HP:0001966) | 0.91549851 |
| 141 | Paraplegia (HP:0010550) | 0.91483288 |
| 142 | Overlapping toe (HP:0001845) | 0.91013318 |
| 143 | Abnormality of the salivary glands (HP:0010286) | 0.90828335 |
| 144 | Bladder diverticulum (HP:0000015) | 0.90293387 |
| 145 | Asymmetry of the thorax (HP:0001555) | 0.90275621 |
| 146 | Coarse hair (HP:0002208) | 0.88670918 |
| 147 | Paraparesis (HP:0002385) | 0.87455405 |
| 148 | Hypopigmented skin patches (HP:0001053) | 0.87054496 |
| 149 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 0.85174615 |
| 150 | Spastic paraparesis (HP:0002313) | 0.84369923 |
| 151 | Atelectasis (HP:0100750) | 0.81945967 |
| 152 | Bladder carcinoma (HP:0002862) | 0.81179355 |
| 153 | Bladder neoplasm (HP:0009725) | 0.81179355 |
| 154 | Myoglobinuria (HP:0002913) | 0.80705077 |
| 155 | Distal sensory impairment (HP:0002936) | 0.78807371 |
| 156 | Aneurysm (HP:0002617) | 0.78800229 |
| 157 | Uterine leiomyosarcoma (HP:0002891) | 0.78627292 |
| 158 | Leiomyosarcoma (HP:0100243) | 0.78627292 |
| 159 | Exostoses (HP:0100777) | 0.78539498 |
| 160 | Angiofibromas (HP:0010615) | 0.78381998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MET | 5.71402680 |
| 2 | PDK2 | 4.25591933 |
| 3 | MARK3 | 3.98003805 |
| 4 | BMX | 3.89546225 |
| 5 | PKN2 | 3.81898737 |
| 6 | WEE1 | 3.13640070 |
| 7 | TRIB3 | 2.56855713 |
| 8 | MAP3K3 | 2.45626198 |
| 9 | CDK3 | 2.03826962 |
| 10 | MST1R | 13.0794816 |
| 11 | PRKD3 | 1.99639057 |
| 12 | EPHA3 | 1.95380385 |
| 13 | TRIM28 | 1.71844589 |
| 14 | PRKCH | 1.58695470 |
| 15 | BMPR1B | 1.54919038 |
| 16 | SCYL2 | 1.53040440 |
| 17 | EIF2AK1 | 1.36658919 |
| 18 | MAP3K2 | 1.32561939 |
| 19 | DDR2 | 1.22384808 |
| 20 | ACVR1B | 1.20256366 |
| 21 | ERBB3 | 1.19568393 |
| 22 | PTK2B | 1.18428289 |
| 23 | LATS1 | 1.16967486 |
| 24 | TTN | 1.14004411 |
| 25 | KIT | 1.11874196 |
| 26 | FLT3 | 1.07395768 |
| 27 | SIK3 | 1.06173191 |
| 28 | NEK1 | 1.04922302 |
| 29 | ICK | 0.99757094 |
| 30 | MATK | 0.99314174 |
| 31 | PTK6 | 0.87941676 |
| 32 | LRRK2 | 0.82896025 |
| 33 | GSK3A | 0.82890175 |
| 34 | BMPR2 | 0.82845126 |
| 35 | CCNB1 | 0.81813140 |
| 36 | NEK6 | 0.77679387 |
| 37 | ABL2 | 0.77562460 |
| 38 | MAP4K1 | 0.67694697 |
| 39 | PAK4 | 0.66437446 |
| 40 | PLK1 | 0.64791678 |
| 41 | RPS6KB2 | 0.64186730 |
| 42 | CSNK1G1 | 0.61544211 |
| 43 | GRK6 | 0.60513209 |
| 44 | ADRBK1 | 0.57678591 |
| 45 | FER | 0.56082577 |
| 46 | CAMKK1 | 0.54425249 |
| 47 | GRK5 | 0.53407405 |
| 48 | PRKD2 | 0.52833695 |
| 49 | KSR2 | 0.51159227 |
| 50 | CSNK1G3 | 0.50690962 |
| 51 | RET | 0.49415279 |
| 52 | KSR1 | 0.49259577 |
| 53 | PDGFRA | 0.48510915 |
| 54 | CSNK1A1L | 0.48247206 |
| 55 | ILK | 0.46788067 |
| 56 | CHUK | 0.46563934 |
| 57 | INSRR | 0.46053142 |
| 58 | RIPK1 | 0.45947858 |
| 59 | MAPK7 | 0.44483579 |
| 60 | OBSCN | 0.44004266 |
| 61 | ADRBK2 | 0.43102507 |
| 62 | CSNK1A1 | 0.40499293 |
| 63 | BRSK1 | 0.40173066 |
| 64 | MAPK13 | 0.39523342 |
| 65 | PRKAA2 | 0.38288462 |
| 66 | AKT2 | 0.37533053 |
| 67 | MAP2K1 | 0.37280949 |
| 68 | CSNK1G2 | 0.36682425 |
| 69 | PRKG2 | 0.36063725 |
| 70 | ZAP70 | 0.35675834 |
| 71 | MAPK11 | 0.34922317 |
| 72 | CDK6 | 0.34388759 |
| 73 | WNK4 | 0.33767381 |
| 74 | CDK18 | 0.33733432 |
| 75 | GRK1 | 0.33482578 |
| 76 | TGFBR1 | 0.33229770 |
| 77 | CDK7 | 0.33212364 |
| 78 | CLK1 | 0.33109409 |
| 79 | ATR | 0.31838427 |
| 80 | PHKG2 | 0.31323786 |
| 81 | PHKG1 | 0.31323786 |
| 82 | MAP3K9 | 0.30395576 |
| 83 | ZAK | 0.30251695 |
| 84 | LMTK2 | 0.29728851 |
| 85 | CDC7 | 0.29360752 |
| 86 | TYK2 | 0.29339197 |
| 87 | STK4 | 0.29056995 |
| 88 | WNK3 | 0.28919481 |
| 89 | DMPK | 0.28815912 |
| 90 | MAP3K8 | 0.28809745 |
| 91 | FGFR4 | 0.27751268 |
| 92 | INSR | 0.27172246 |
| 93 | MAP3K13 | 0.26813799 |
| 94 | MAPKAPK5 | 0.26483822 |
| 95 | CDK11A | 0.26265021 |
| 96 | CDK15 | 0.25698989 |
| 97 | EEF2K | 0.24856149 |
| 98 | CAMKK2 | 0.24766529 |
| 99 | PRKCE | 0.23876168 |
| 100 | FRK | 0.23477802 |
| 101 | DYRK1A | 0.23341582 |
| 102 | PAK6 | 0.23155671 |
| 103 | MAP3K11 | 0.22848966 |
| 104 | TAOK3 | 0.22780376 |
| 105 | ATM | 0.22614627 |
| 106 | TBK1 | 0.22115988 |
| 107 | PRKCZ | 0.21955870 |
| 108 | MAPK12 | 0.20959402 |
| 109 | EGFR | 0.20817313 |
| 110 | BCKDK | 0.20391162 |
| 111 | MAPKAPK3 | 0.20389123 |
| 112 | ALK | 0.19437809 |
| 113 | CHEK2 | 0.19409583 |
| 114 | LATS2 | 0.18974737 |
| 115 | RAF1 | 0.18748338 |
| 116 | FGFR1 | 0.17343772 |
| 117 | CDK4 | 0.17188751 |
| 118 | FGFR3 | 0.16763112 |
| 119 | STK3 | 0.16566258 |
| 120 | BRSK2 | 0.16320909 |
| 121 | NEK2 | 0.16058223 |
| 122 | TLK1 | 0.15535978 |
| 123 | PAK3 | 0.15263762 |
| 124 | PAK2 | 0.15024943 |
| 125 | NTRK1 | 0.14600942 |
| 126 | RPS6KA1 | 0.14305092 |
| 127 | FGFR2 | 0.14023462 |
| 128 | CSNK1D | 0.12670339 |
| 129 | PDGFRB | 0.10895540 |
| 130 | IGF1R | 0.10801528 |
| 131 | TGFBR2 | 0.10089239 |
| 132 | FGR | 0.09734026 |
| 133 | PLK3 | 0.09722991 |
| 134 | ABL1 | 0.09375239 |
| 135 | TYRO3 | 0.08933707 |
| 136 | ARAF | 0.08796166 |
| 137 | SRC | 0.08589807 |
| 138 | SGK3 | 0.08212677 |
| 139 | PRKACB | 0.07975824 |
| 140 | CAMK1D | 0.07775574 |
| 141 | MAPK3 | 0.07215727 |
| 142 | PLK2 | 0.06740033 |
| 143 | DYRK1B | 0.06027091 |
| 144 | EIF2AK3 | 0.05091479 |
| 145 | NEK9 | 0.05066659 |
| 146 | PTK2 | 0.04784011 |
| 147 | MOS | 0.04464591 |
| 148 | SGK2 | 0.03977254 |
| 149 | MTOR | 0.03534661 |
| 150 | PRKD1 | 0.03422999 |
| 151 | ERBB2 | 0.03412934 |
| 152 | AURKA | 0.03210960 |
| 153 | TRPM7 | 0.03020624 |
| 154 | AKT1 | 0.02935660 |
| 155 | MAP2K6 | 0.01996161 |
| 156 | PDK1 | 0.01756692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Melanogenesis_Homo sapiens_hsa04916 | 3.97700654 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.79216374 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.37329298 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.80468112 |
| 5 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.74923444 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72610693 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.39172598 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.30491873 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.25345275 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.19313099 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14950388 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.11027257 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.06401790 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.03839683 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.01514825 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 10.4097370 |
| 17 | Melanoma_Homo sapiens_hsa05218 | 1.94838431 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.92204330 |
| 19 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.90162860 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.86791763 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74057186 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73912942 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70517661 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62605416 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62513177 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.60131741 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56369437 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.55040984 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.46472617 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45853657 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44767099 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40513989 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32898544 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.32864354 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30734653 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29896070 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.29893896 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.26693702 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25797769 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22963946 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19523254 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17915842 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.12337135 |
| 44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11283362 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09048988 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.02636764 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01853818 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01250753 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00172079 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99405408 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98935047 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93138629 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92327885 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89965548 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 0.89253012 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85734273 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.82452482 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79808111 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77024609 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.76567177 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76495753 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.76412024 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74780473 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74319938 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73782251 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.73112634 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.69968149 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69580413 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.67402271 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67152561 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67087703 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66295099 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65471481 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63715491 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62591399 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61847267 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61748732 |
| 78 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60974911 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59820686 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59367435 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.59050722 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57439152 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56954745 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.56625774 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50061835 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49321125 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49081618 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49053537 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.48740814 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46720855 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46629002 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45245331 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44967935 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.44207275 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43053280 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41940550 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40278812 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40037209 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39090895 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.38690218 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38460865 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37694727 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36776760 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.36200378 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35892982 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35737285 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33323323 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32403070 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31781466 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31198553 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29841854 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28307719 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28110503 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27501867 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27457847 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27037840 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26619320 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25574039 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23792180 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23162724 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23123499 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.22930407 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22754332 |
| 124 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.22665743 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22521971 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22326917 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21788831 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21705376 |
| 129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.21403550 |
| 130 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21101946 |
| 131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20057443 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20016725 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19685022 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19549807 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19534445 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18493575 |
| 137 | Mismatch repair_Homo sapiens_hsa03430 | 0.17212889 |
| 138 | Olfactory transduction_Homo sapiens_hsa04740 | 0.16718358 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.16690771 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16398288 |
| 141 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.15798894 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.15751613 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15722281 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.15627534 |
| 145 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.15284681 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14834691 |
| 147 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14321080 |
| 148 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.14157486 |
| 149 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.13256674 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13192159 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13159294 |
| 152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.12819132 |
| 153 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.12682106 |
| 154 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.12680457 |
| 155 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.11943080 |
| 156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11722219 |
| 157 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11376088 |
| 158 | Cell cycle_Homo sapiens_hsa04110 | 0.11335780 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10820284 |

